Truepoint Inc’s GE HealthCare GEHC Stock Holding History

Truepoint Inc’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,264	Closed	-$222K	–	253
2023 Q3	$222K	Buy	+3,264	New	+$237K	0.01%	183

Other funds holding GEHC

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Truepoint Inc's GEHC Position: Q4 2023 in Review

Truepoint Inc sold out of GE HealthCare (GEHC) in Q4 2023, closing a stake of 3,264 shares — an estimated $222K sold.

Truepoint Inc first reported a position in GEHC in Q3 2023 and held it in 1 quarter. The position peaked at $222K in Q3 2023. 1,186 funds tracked by Wall St. Rank hold GEHC as of Q4 2023.

Truepoint Inc reported no remaining GE HealthCare position as of Q4 2023 after selling out during the quarter.
Truepoint Inc sold 3,264 GE HealthCare shares in Q4 2023, an estimated $222K.
Truepoint Inc first reported a position in GE HealthCare in Q3 2023 and held it in 1 quarter.
Truepoint Inc's GE HealthCare position peaked at $222K in Q3 2023.
1,186 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2023.

Based on Truepoint Inc's 13F filing for Q4 2023, filed 12 Feb 2024.